Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic Malignancies

Authors :: Manish R. Patel
William Donnellan
Michael Byrne
Adam S. Asch
Amer M. Zeidan
Maria R. Baer
Amir T. Fathi
Andrew T. Kuykendall
Fred Zheng
Chris Walker
Lulu Cheng
Cindy Marando
Michael R. Savona
Source :: Clinical Lymphoma Myeloma and Leukemia.
Publication Year :: 2023
Publisher :: Elsevier BV, 2023.

Tools